newsfilter
← Latest News
GlobeNewswire·

Invizyne's Nasdaq IPO Marks New Era of Biomanufacturing

Monrovia, CA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Today, Invizyne Technologies, Inc., (NASDAQ:IZTC) ("Invizyne"), a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially